INCATE supports innovators
to fight drug-resistant bacterial infections
Our Mission
Supporting innovators to fight drug-resistant infections
INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe to accelerate your innovation. We do this by providing advice, community and funding. Our focus is on the development of new therapies, and interventions that help reduce the prevalence and impact of Antimicrobial Resistance (AMR).
Whats up?
Latest News
The INCATE Management team is happy to announce the release of INCATE’s first report, covering our work from 2021 to the end of 2024. This milestone provides a comprehensive overview of who we are, how [...]
A collaborative research program led by the Helmholtz Centre for Infection Research (HZI) in Braunschweig, [...]
Couldn’t make it to our latest Entrepreneurs Club session, or want to revisit the discussion? [...]
The INCATE Team is happy to share some exciting news: the INCATE Selection Committee has [...]
Over the past four years, INCATE has been supporting early-stage ventures working on innovations to [...]
What we do
Supporting your venture
Advice
Advice from partners, including Industry, to enable; early alignment with medical needs and market demand, the development of a quality translational path and a plan to build a company.
Community
Access to a community of engaged individuals across industry, academia, entrepreneurs, policymakers, investors, public health and healthcare providers to share ideas and fight drug-resistant bacterial infections together.
Funding
Up to €250,000 in non-dilutive funding will be provided to selected projects to help answer critical questions needed to develop business and translational plans to convince investors at the next funding stage.
